透明细胞肾细胞癌的胆固醇营养缺陷可作为可靶向脆弱点
透明细胞肾细胞癌(ccRCC)细胞内虽富含胆固醇酯滴,但胆固醇生物合成酶基因表达受抑,提示其依赖外源胆固醇。基于约31000人的孟德尔随机化分析显示,循环高密度脂蛋白(HDL)胆固醇升高与ccRCC风险存在因果关联。剥夺ccRCC细胞的胆固醇或HDL可损害体外增殖与存活及体内肿瘤生长,而膳食胆固醇升高则促进肿瘤生长;SCARB1是胆固醇摄取所必需,抑制SCARB1足以导致细胞周期阻滞、凋亡、活性氧升高及PI3K/AKT信号下降。
要点
- ccRCC细胞胆固醇合成基因受抑,依赖外源胆固醇维持PI3K/AKT信号与ROS稳态。
- HDL胆固醇升高与ccRCC风险存在因果关联,SCARB1是胆固醇摄取的关键转运体。
- 抑制SCARB1可诱导ccRCC细胞周期阻滞、凋亡并抑制肿瘤生长,为潜在治疗靶点。
核心结论
- ccRCC细胞对外源胆固醇存在依赖,SCARB1介导的胆固醇摄取是其可靶向的脆弱点。
研究设计与样本
- 研究纳入ccRCC细胞模型与体内肿瘤模型,并结合基于约31000人的孟德尔随机化分析。
主要发现
- ccRCC中胆固醇生物合成酶基因表达受抑,提示依赖外源胆固醇。
- 基于约31000人的孟德尔随机化分析提示循环HDL胆固醇升高与ccRCC风险存在因果关联。
- 剥夺ccRCC细胞的胆固醇或HDL可损害体外增殖与存活及体内肿瘤生长,而膳食胆固醇升高促进肿瘤生长。
- 抑制SCARB1足以导致ccRCC细胞周期阻滞、凋亡、细胞内活性氧升高及PI3K/AKT信号下降。
临床怎么用
- SCARB1可作为ccRCC潜在治疗靶点,阻断胆固醇摄取可能抑制肿瘤生长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Clear cell renal cell carcinoma (ccRCC) is characterized by large intracellular lipid droplets containing free and esterified cholesterol; however, the functional significance of cholesterol accumulation in ccRCC cells is unknown. We demonstrate that, surprisingly, genes encoding cholesterol biosynthetic enzymes are repressed in ccRCC, suggesting a dependency on exogenous cholesterol. Mendelian randomization analyses based on 31,000 individuals indicate a causal link between elevated circulating high-density lipoprotein (HDL) cholesterol and ccRCC risk. Depriving ccRCC cells of either cholesterol or HDL compromises proliferation and survival in vitro and tumor growth in vivo; in contrast, elevated dietary cholesterol promotes tumor growth. Scavenger Receptor B1 (SCARB1) is uniquely required for cholesterol import, and inhibiting SCARB1 is sufficient to cause ccRCC cell-cycle arrest, apoptosis, elevated intracellular reactive oxygen species levels, and decreased PI3K/AKT signaling. Collectively, we reveal a cholesterol dependency in ccRCC and implicate SCARB1 as a novel therapeutic target for treating kidney cancer. SIGNIFICANCE: We demonstrate that ccRCC cells are auxotrophic for exogenous cholesterol to maintain PI3K/AKT signaling pathway and ROS homeostasis. Blocking cholesterol import through the HDL transporter SCARB1 compromises ccRCC cell survival and tumor growth, suggesting a novel pharmacologic target for this disease. This article is highlighted in the In This Issue feature, p. 2945.
引用
- Riscal R, Bull CJ, Mesaros C, et al. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma. Cancer Discov. 2021. PMID: 34244212. doi:10.1158/2159-8290.CD-21-0211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。